PT Bio Farma (Persero) - Recruitment D3, S1, S2 Science, Non Science June 2012

Advertisement

PT Bio Farma (Persero) / biofarma.co.id

PT Bio Farma (Persero) - Bio Farma is a respective state owned company (BUMN) located in Bandung and engaged in Pharmacy industry. The Company founded in 1890 under the name of "Parc Vaccinogene" and its name changed into PT Bio Farma (Persero) in 1997. The Company currently operated as the one vaccine and antisera producer in Indonesia and South East Asia. The Company supported by 2 (two) plants, located in Jl Pasteur Bandung (for Production, R&D, Marketing and Administration) and Cisarua Lembang Bandung (for laboratory pet breeding and maintenance). PT Bio Farma (Persero) awared the Good Manufacturing Practices (GMP) certification from National Agency for Drug and Food Control (NADFC). The Company also obtained several certifications, consist fo : the Quality Management System ISO 9001 : 2008, ISO 14001 : 2004, and OHSAS 18001 : 2007.

In line with its vision, to become a vaccine and anti sera producer of global competitiveness, currently PT Bio Farma (Persero) are looking for a competent and talented person in the field of:

Science
Majoring in : Pharmacy, Chemistry, Biology, Biotechnology, Microbiology, General Medicine, Veterinary, Health Analyst, Analyst Chemistry, Chemical Engineering, Environmental Health, Environmental Engineering, Mechanical Engineering, Electrical Engineering, Mechatronics, Informatics, Nursing

Non Science
Majoring in : Accounting, Economic Management, Risk Management, Law, Marketing, Communication Science

General Requirements :

• Minimum D3, S1, S2 graduates
• Min GPA 

1. Accreditation A : 2.75
2. Accreditation B : 3.00
3. Accreditation C : 3.25

• Male or Female with age range 21 - 30 years old

For further information, please refer official source from PT Bio Farma (Persero) on following link below. Should you interested, please register yourself at Bio Farma Career Website not later than 16 June 2012. Only short-listed candidates will be notified.
Official Source

By Andi Kurniawan with No comments